BriaCell Therapeutics Corp.

Develops off-the-shelf cellular immunotherapies for advanced breast, prostate, and lung cancers.

BCTX | NDAQ

Overview

Corporate Details

ISIN(s):: CA10778Y3007 (+1 more)
LEI:
Country:: United States of America
Address:: 3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR, WEST VANCOUVER
Website:: https://briacell.com/
Sector:: Mining and quarrying
Industry:: Mining of non-ferrous metal ores

Description

BriaCell Therapeutics Corp. is a clinical-stage immuno-oncology company developing targeted cellular immunotherapies to activate the patient's immune system against cancer. Its lead candidate, Bria-IMT™, is a patented, off-the-shelf cell-based therapy in a pivotal Phase 3 study for advanced metastatic breast cancer. Bria-IMT™ has received FDA Fast Track designation and has shown efficacy in heavily pre-treated patients, including those with central nervous system metastases. The company is also advancing its next-generation Bria-OTS™ platform, which provides personalized, off-the-shelf treatments matched to a patient's HLA type. The Bria-OTS™ platform is being evaluated in a Phase 1/2 clinical trial for multiple cancers, including breast, prostate, and lung cancer.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all BriaCell Therapeutics Corp. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for BriaCell Therapeutics Corp.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for BriaCell Therapeutics Corp. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
GENFLOW BIOSCIENCES PLC Develops gene therapies to slow aging and treat age-related diseases in humans and dogs.	United Kingdom	GENF
GENINUS Inc. AI-powered genomic and multi-omics analysis for precision medicine and clinical partners.	South Korea	389030
genOway Develops custom genetically modified preclinical models for biopharma and academic research.	France	ALGEN
Genpact LTD Drives business transformation for enterprises using AI, data, and technology services.	United States of America	G
GenSight Biologics S.A. Developing gene therapies for neurodegenerative diseases of the eye and central nervous system.	France	SIGHT
GeoVax Labs, Inc. Developing vaccines and immunotherapies for infectious diseases and cancer using proprietary platforms.	United States of America	GOVX
GEZİNOMİ SEYAHAT TURİZM TİCARET A.Ş. A travel agency offering online booking for transport, hotels, cultural tours, and cruises.	Türkiye	GZNMI
GIG Works Inc. Connects businesses with gig workers, offering staffing, BPO, IT, and coworking services in Japan.	Japan	2375
Globe Capital Limited An investment company providing global marketing and promotion services, focusing on UK businesses.	Cayman Islands	GCAP
GMO Research & AI, Inc. Market research tech providing access to 65M+ APAC consumer panelists for data-driven insights.	Japan	3695